Global IRB WIRB-Copernicus Group (WCG) Will Encourage the 1,200 Members of its Global Research Network to Accept and Use the Accelerated Clinical Trial Agreement

WCG’s President of Institutions & Institutional Services, Stuart Horowitz, PhD, MBA, discusses the encouragement of the Accelerated Clinical Trial Agreement (ACTA) for its 1,200 member institutions in an interview with CenterWatch Weekly’s Ron Rosenberg.

Publication: CenterWatch Weekly